Storia in 18 fonti

AstraZeneca se spaja s američkim divom. Posao vrijedi 350 milijardi eura

ASTRAZENECA pregovara o spajanju s američkim Bristol Myers Squibbom vrijednom 350 milijardi eura. Potez stvara sumnje u dugoročnu vezanost britanske tvrtke za UK, unatoč obećanjima o ostanku.

Raccontata da

www1.folha.uol.com.br

ilsole24ore.com+6 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

index.hrStai leggendo1 g fa

AstraZeneca se spaja s američkim divom. Posao vrijedi 350 milijardi eura

ASTRAZENECA pregovara o spajanju s američkim Bristol Myers Squibbom vrijednom 350 milijardi eura. Potez stvara sumnje u dugoročnu vezanost britanske tvrtke za UK, unatoč obećanjima o ostanku.

originale

Timeline cronologica

domenica 2 agosto 2026·www1.folha.uol.com.br
AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi
Acordo pode criar a quarta maior farmacêutica do mundo por capitalização de mercado
domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…

AstraZeneca se spaja s američkim divom. Posao vrijedi 350 milijardi eura

Confronto fonti

AstraZeneca se spaja s američkim divom. Posao vrijedi 350 milijardi eura

Timeline cronologica

AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca e Bristol Myers Squibb, prove di fusione

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Pharma: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch

Ft: «AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi» - Lettera43

AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

AstraZeneca se spaja s američkim divom. Posao vrijedi 350 milijardi eura

La potentielle fusion avec Bristol-Myers Squibb fait plonger AstraZeneca - Le Temps

Media, AstraZeneca tratta con Bristol Myers Squibb: maxi fusione da 400 miliardi

Ft, AstraZeneca tratta con Bristol Myers Squibb maxi fusione da 400 miliardi

Ft: AstraZeneca tratta con Bristol Myers Squibb fusione da 400 mld

Pharma: Astra-Zeneca erwägt wohl Mega-Fusion mit Bristol-Myers Squibb

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Financial Times: 'AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi' - Notizie - Ansa.it